The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-time evidence synthesis for first line (1L) treatment of metastatic renal cell carcinoma (mRCC): A living, interactive systematic review and Bayesian network meta-analysis.
 
Syed Arsalan Ahmed Naqvi
No Relationships to Disclose
 
Huan He
No Relationships to Disclose
 
Rabbia Siddiqi
No Relationships to Disclose
 
Nihal Ijaz Khan
No Relationships to Disclose
 
Kaneez Zahra Rubab Khakwani
No Relationships to Disclose
 
Ahsan Ayaz
No Relationships to Disclose
 
Parminder Singh
Honoraria - Curio Science; Medpage/ASCO
Consulting or Advisory Role - AVEO; Bayer; EMD Serono; Janssen Oncology; Seattle Genetics/Astellas (Inst)
Research Funding - EMD Serono (Inst)
(OPTIONAL) Uncompensated Relationships - Seagen
 
Thai Huu Ho
No Relationships to Disclose
 
Alan Haruo Bryce
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZeneca; Bayer; Castle Biosciences; Horizon CME; Myovant Sciences; Myovant Sciences; Pfizer; Research to Practice; Research to Practice; Verity Pharmaceuticals
Travel, Accommodations, Expenses - Clovis Oncology (Inst); Phosplatin Therapeutics (Inst)
 
Bradley Alexander McGregor
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Genentech/Roche; Merck; Pfizer; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Pfizer/EMD Serono (Inst); Seattle Genetics/Astellas (Inst)
 
Wenxin (Vincent) Xu
No Relationships to Disclose
 
Irbaz Bin Riaz
No Relationships to Disclose